(19)
(11) EP 4 739 660 A1

(12)

(43) Date of publication:
13.05.2026 Bulletin 2026/20

(21) Application number: 24835428.4

(22) Date of filing: 05.07.2024
(51) International Patent Classification (IPC): 
C07D 233/90(2006.01)
C07D 403/04(2006.01)
A61P 35/00(2006.01)
 C07D 405/04(2006.01)
A61K 31/4164(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 35/00; C07D 233/90; C07C 53/10; C07C 57/15
(86) International application number:
PCT/CN2024/103817
(87) International publication number:
WO 2025/007950 (09.01.2025 Gazette 2025/02)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 06.07.2023 WO PCT/CN2023/106164
24.06.2024 WO PCT/CN2024/101076

(71) Applicant: Insilico Medicine IP Limited
Hong Kong (HK)

(72) Inventors:
  • LIANG, Xing
    Shanghai 201203 (CN)
  • WANG, Hui
    Shanghai 201203 (CN)
  • YIN, Yushu
    Shanghai 201203 (CN)

(74) Representative: Vossius & Partner Patentanwälte Rechtsanwälte mbB 
Siebertstraße 3
81675 München
81675 München (DE)

   


(54) CRYSTALLINE TNIK INHIBITOR AND USES THEREOF